Literature DB >> 16887809

Lipidic antagonists to SNARE-mediated fusion.

Thomas J Melia1, Daoqi You, David C Tareste, James E Rothman.   

Abstract

SNARE proteins mediate the fusion of lipid bilayers by the directed assembly of coiled-coil domains arising from apposing membranes. We have utilized inverted cone-shaped lipids, antagonists of the necessary membrane deformation during fusion to characterize the extent and range of SNARE assembly up to the moment of stalk formation between bilayers. The inverted cone-shaped lipid family of acyl-CoAs specifically inhibits the completion of fusion in an acyl-chain length-dependent manner. Removal of acyl-CoA from the membrane relieves the inhibition and initiates a burst of membrane fusion with rates exceeding any point in the control curves lacking acyl-CoA. This burst indicates the accumulation of semi-assembled fusion complexes. These preformed complexes are resistant to cleavage by botulinum toxin B and thus appear to have progressed beyond the "loosely zippered" state of docked synaptic vesicles. Surprisingly, application of the soluble domain of VAMP2, which blocks SNARE assembly by competing for binding on the available t-SNAREs, blocks recovery from the acyl-CoA inhibition. Thus, complexes formed in the presence of a lipidic antagonist to fusion are incompletely assembled, suggesting that the formation of tightly assembled SNARE pairs requires progression all the way through to membrane fusion. In this regard, physiologically docked exocytic vesicles may be anchored by a highly dynamic and potentially even reversible SNAREpin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887809     DOI: 10.1074/jbc.M601778200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Protein determinants of SNARE-mediated lipid mixing.

Authors:  Hong Ji; Jeff Coleman; Rong Yang; Thomas J Melia; James E Rothman; David Tareste
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

2.  Membrane hemifusion is a stable intermediate of exocytosis.

Authors:  Julian L Wong; Dennis E Koppel; Ann E Cowan; Gary M Wessel
Journal:  Dev Cell       Date:  2007-04       Impact factor: 12.270

3.  Docking, not fusion, as the rate-limiting step in a SNARE-driven vesicle fusion assay.

Authors:  Elizabeth A Smith; James C Weisshaar
Journal:  Biophys J       Date:  2011-05-04       Impact factor: 4.033

4.  The SNAP-25 linker supports fusion intermediates by local lipid interactions.

Authors:  Ahmed Shaaban; Madhurima Dhara; Walentina Frisch; Ali Harb; Ali H Shaib; Ute Becherer; Dieter Bruns; Ralf Mohrmann
Journal:  Elife       Date:  2019-03-18       Impact factor: 8.140

5.  SNARE-mediated Fusion of Single Proteoliposomes with Tethered Supported Bilayers in a Microfluidic Flow Cell Monitored by Polarized TIRF Microscopy.

Authors:  Joerg Nikolaus; Erdem Karatekin
Journal:  J Vis Exp       Date:  2016-08-24       Impact factor: 1.355

Review 6.  Lipid dynamics in exocytosis.

Authors:  S Chasserot-Golaz; J R Coorssen; F A Meunier; N Vitale
Journal:  Cell Mol Neurobiol       Date:  2010-11-16       Impact factor: 5.046

7.  Inner/Outer nuclear membrane fusion in nuclear pore assembly: biochemical demonstration and molecular analysis.

Authors:  Boris Fichtman; Corinne Ramos; Beth Rasala; Amnon Harel; Douglass J Forbes
Journal:  Mol Biol Cell       Date:  2010-10-06       Impact factor: 4.138

8.  SNARE-catalyzed fusion events are regulated by Syntaxin1A-lipid interactions.

Authors:  Alice D Lam; Petra Tryoen-Toth; Bill Tsai; Nicolas Vitale; Edward L Stuenkel
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

9.  Phosphatidylinositol-4,5-bisphosphate and phospholipase D-generated phosphatidic acid specify SNARE-mediated vesicle fusion for prospore membrane formation.

Authors:  Rima Mendonsa; JoAnne Engebrecht
Journal:  Eukaryot Cell       Date:  2009-06-05

10.  Capture and release of partially zipped trans-SNARE complexes on intact organelles.

Authors:  Matthew L Schwartz; Alexey J Merz
Journal:  J Cell Biol       Date:  2009-05-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.